Common TitleDRIVE BEYOND
Official Title A Phase IIa Multicenter, Open-Label Clinical Trial to Evaluate the Safety and Efficacy of Doravirine-Tenofovir disoproxil fumarate-Lamivudine (MK-1439A) in Treatment-Naïve HIV-1 Infected Subjects With Selected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Transmitted Resistance Mutations
Phase Phase IIA
ClinicalTrials.gov NCT02629822
Treatments
Doravirine-Tenofovir DF-Lamivudine
Doravirine-Tenofovir DF-Lamivudine
Tradename:DelstrigoOther Names:DOR-TDF-3TC, Doravirine-Tenofovir disoproxil fumarate-LamivudineClass:Single-Tablet RegimensFunding
IndustryMerck